View Item 

Show simple item record

Mechanism of Action and Structural Requirements of Constrained Peptide Inhibitors of RGS Proteins

dc.contributor.authorRoof, Rebecca A.en_US
dc.contributor.authorJin, Yafeien_US
dc.contributor.authorRoman, David L.en_US
dc.contributor.authorSunahara, Roger K.en_US
dc.contributor.authorIshii, Masaruen_US
dc.contributor.authorMosberg, Henry I.en_US
dc.contributor.authorNeubig, Richard R.en_US
dc.date.accessioned2010-04-01T15:42:33Z
dc.date.available2010-04-01T15:42:33Z
dc.date.issued2006-04en_US
dc.identifier.citationRoof, Rebecca A.; Jin, Yafei; Roman, David L.; Sunahara, Roger K.; Ishii, Masaru; Mosberg, Henry I.; Neubig, Richard R. (2006). "Mechanism of Action and Structural Requirements of Constrained Peptide Inhibitors of RGS Proteins." Chemical Biology & Drug Design 67(4): 266-274. <http://hdl.handle.net/2027.42/66199>en_US
dc.identifier.issn1747-0277en_US
dc.identifier.issn1747-0285en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66199
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16629824&dopt=citationen_US
dc.format.extent374224 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 The Authors Journal compilation 2006 Blackwell Munksgaarden_US
dc.subject.otherG Proteinen_US
dc.subject.otherGTPase Activating Proteinen_US
dc.subject.otherStructure Based Drug Designen_US
dc.titleMechanism of Action and Structural Requirements of Constrained Peptide Inhibitors of RGS Proteinsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, 1150 W. Medical Center Dr, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDepartment of Medicinal Chemistry, 428 Church Street, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationotherDepartment of Pharmacology II, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japanen_US
dc.identifier.pmid16629824en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66199/1/j.1747-0285.2006.00373.x.pdf
dc.identifier.doi10.1111/j.1747-0285.2006.00373.xen_US
dc.identifier.sourceChemical Biology & Drug Designen_US
dc.identifier.citedreferenceHepler J.R. ( 1999 ) Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci ; 20 : 376 – 382.en_US
dc.identifier.citedreferenceBerman D.M., Kozasa T., Gilman A.G. ( 1996 ) The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem ; 271 : 27209 – 27212.en_US
dc.identifier.citedreferenceTraynor J.R., Neubig R.R. ( 2005 ) Regulators of G protein signaling and drugs of abuse. Mol Interv ; 5 : 30 – 41.en_US
dc.identifier.citedreferenceWang Q., Liu M., Mullah B., Siderovski D.P., Neubig R.R. ( 2002 ) Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J Biol Chem ; 277 : 24949 – 24958.en_US
dc.identifier.citedreferenceXu X, Zeng W., Popov S., Berman D.M, Davignon I., Yu K., Yowe D., Offermann S., Muallem S., Wilkie T.M. ( 1999 ) RGS proteins determine signaling specificity of Gq-coupled receptors. J Biol Chem 274 : 3549 – 3556.en_US
dc.identifier.citedreferenceGhavami A., Hunt R.A., Olsen M.A., Zhang J., Smith D.L., Kalgaonkar S., Rahman Z., Young K.H. ( 2004 ) Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity. Cell Signal 16 : 711 – 721.en_US
dc.identifier.citedreferenceHague C., Bernstein L.S., Ramineni S., Chen Z., Minneman K.P., Hepler J.R. ( 2005 ) Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem ; 280 : 27289 – 27295.en_US
dc.identifier.citedreferenceKrumins A.M., Barker S.A., Huang C., Sunahara R.K., Yu K., Wilkie T.M., Gold S.J., Mumby S.M. ( 2004 ) Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem 279 : 2593 – 2599.en_US
dc.identifier.citedreferenceWieland T., Mittmann C. ( 2003 ) Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther ; 97 : 95 – 115.en_US
dc.identifier.citedreferenceGold S.J., Ni Y.G., Dohlman H.G., Nestler E.J. ( 1997 ) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci ; 17 : 8024 – 8037.en_US
dc.identifier.citedreferenceNeubig R.R., Siderovski D.P. ( 2002 ) Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov ; 1 : 187 – 197.en_US
dc.identifier.citedreferenceZhong H., Neubig R.R. ( 2001 ) Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther ; 297 : 837 – 845.en_US
dc.identifier.citedreferenceStandaert D.G., Young A.B. ( 2001 ) Treatment of central nervous system degenerative disorders. In: Hardman J.G., Limbird L.E., editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, USA : McGraw Hill ; p. 549 – 568.en_US
dc.identifier.citedreferenceUsui I., Imamura T., Satoh H., Huang J., Babendure J.L., Hupfeld C.J., Olefsky J.M. ( 2004 ) GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transtport stimulation. EMBO J 23 : 2821 – 2829.en_US
dc.identifier.citedreferenceRiddle E.L., Schwartzman R.A., Bond M., Insel P.A. ( 2005 ) Multi-tasking RGS proteins in the heart: the next therapeutic target ? Circ Res ; 96 : 401 – 411.en_US
dc.identifier.citedreferenceDruey K.M. ( 2003 ) Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthma. Expert Opin Ther Targets ; 7 : 475 – 484.en_US
dc.identifier.citedreferenceBerman D.M., Wang Y., Liu Z., Dong Q., Burke L.A., Liotta L.A., Fiser R., Wu X. ( 2004 ) A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res 64 : 6820 – 6826.en_US
dc.identifier.citedreferenceHiol A., Davey P.C., Osterhout J.L., Waheed A.A., Fischer E.R., Chen C.K., Millgan G., Druey K.M., Jones T.L. ( 2003 ) Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function. I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. J Biol Chem 278 : 19301 – 19308.en_US
dc.identifier.citedreferenceBernstein L.S., Grillo A.A., Loranger S.S., Linder M.E. ( 2000 ) RGS4 binds to membranes through an amphipathic alpha-helix. J Biol Chem ; 275 : 18520 – 18526.en_US
dc.identifier.citedreferenceBernstein L.S., Ramineni S., Hague C., Cladman W., Chidiac P., Levey A.I., Hepler J.R. ( 2004 ) RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem 279 : 21248 – 56.en_US
dc.identifier.citedreferenceTesmer J.J., Berman D.M., Gilman A.G., Sprang S.R. ( 1997 ) Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell ; 89 : 251 – 261.en_US
dc.identifier.citedreferenceJin Y., Zhong H., Omnaas J.R., Neubig R.R., Mosberg H.I. ( 2004 ) Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors. J Pept Res ; 63 : 141 – 146.en_US
dc.identifier.citedreferenceJameson E.E., Roof R.A., Whorton M.R., Mosberg H.I., Sunahara R.K., Neubig R.R., Kennedy R.T. ( 2005 ) Real-time detection of basal and stimulated G protein GTPase activity using fluorescent GTP analogues. J Biol Chem 280 : 7712 – 7719.en_US
dc.identifier.citedreferenceLan K.L., Zhong H., Nanamori M., Neubig R.R. ( 2000 ) Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7. J Biol Chem ; 275 : 33497 – 33503.en_US
dc.identifier.citedreferenceLan K.L., Sarvazyan N.A., Taussig R., Mackenzie R.G., DiBello P.R., Dohlman H.G., Neubig R.R. ( 1998 ) Point mutation in Galphao and Galphail blocks interaction with regulator of G protein signaling proteins. J Biol Chem 273 : 12794 – 12797.en_US
dc.identifier.citedreferenceLee E., Linder M.E., Gilman A.G. ( 1994 ) Expression of G-protein alpha subunits in Escherichia coli. Methods Enzymol ; 237 : 146 – 164.en_US
dc.identifier.citedreferenceIshii M., Inanobe A., Fujita S., Makino Y., Hosoya Y., Kurachi Y. ( 2001 ) Ca(2+) elevation evoked by membrane depolarization regulates G protein cycle via RGS proteins in the heart. Circ Res ; 89 : 1045 – 1050.en_US
dc.identifier.citedreferenceDoupnik C.A., Xu T., Shinaman J.M. ( 2001 ) Profile of RGS expression in single rat atrial myocytes. Biochim Biophys Acta ; 1522 : 97 – 107.en_US
dc.identifier.citedreferenceKardestuncer T., Wu H., Lim A.L., Neer E.J. ( 1998 ) Cardiac myocytes express mRNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria. FEBS Lett ; 438 : 285 – 288.en_US
dc.identifier.citedreferenceSowell M.O., Ye C., Ricupero D.A., Hansen S., Quinn S.J., Vassilev P.M., Mortensen R.M. ( 1997 ) Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells. Proc Natl Acad Sci U S A 94 : 7921 – 7926.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1747-0285.2006.00373.x.pdf
Size:
365.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.